RPSAP41: A Drug Target / Disease Biomarker (G100270918)

Target Name: RPSAP41

NCBI ID: G100270918

RPSAP41

Other Name(s): ribosomal protein SA pseudogene 41 | RPSA_17_711 | Ribosomal protein SA pseudogene 41

RPSAP41: A Drug Target / Disease Biomarker

RNA-protein interactions are a crucial aspect of gene regulation and have been implicated in numerous diseases, including cancer. One such interaction that has received increasing attention in recent years is the RNA-protein interaction between RPSAP41 and its protein targets. RPSAP41 is a RNA-protein complex that plays a key role in regulating gene expression and has been implicated in various diseases, including cancer. In this article, we will explore the RPSAP41-protein interaction and its potential as a drug target or biomarker.

The RPSAP41 complex is a protein-RNA interaction that plays a critical role in regulating gene expression and cell biology. RPSAP41 is a protein that contains a N-terminal domain that is involved in protein-protein interactions and a C-terminal domain that is involved in protein-RNA interactions. The N-terminal domain is composed of a unique farnesylated cysteine that is prone to oxidation and modification, which can affect the stability and localization of the protein. The C-terminal domain is composed of a unique lysine that is involved in the formation of a RNA-protein complex and is known as the N-terminal domain-binding protein (NBD).

RPSAP41 has been shown to play a role in regulating gene expression by interacting with various proteins and RNA molecules. One of the most well-studied interactions between RPSAP41 and its protein targets is the interaction between RPSAP41 and the protein targets of the heat shock transcription factor (HSF). HSF is a protein that plays a critical role in regulating gene expression in response to temperature and other stressors. RPSAP41 has been shown to interact with HSF and regulate its activity, which in turn affects gene expression.

In addition to its interaction with HSF, RPSAP41 has also been shown to interact with other proteins, including the transcription factor AP-1 and the protein coding for the tumor suppressor protein p53. These interactions have been shown to play a critical role in regulating gene expression and are potential drug targets or biomarkers for the development of various diseases.

The potential applications of RPSAP41 as a drug target or biomarker are vast and varied. For example, RPSAP41 has been shown to be a potential drug target for the treatment of various cancers, including breast, ovarian, and prostate cancers. The N-terminal domain of RPSAP41 is prone to oxidation and modification, which can affect its stability and localization, making it an attractive target for small molecules. In addition, the C-terminal domain of RPSAP41 is involved in the formation of a RNA-protein complex, which can be targeted by small molecules that disrupt this interaction.

Another potential application of RPSAP41 as a drug target or biomarker is its potential as a biomarker for various diseases, including cancer. The regulation of gene expression by RPSAP41 is disrupted in many diseases, including cancer, which allows for the production of unique genetic alterations in the disease. The N-terminal domain of RPSAP41 is prone to oxidation and modification, which can affect its stability and localization, making it an attractive target for small molecules that disrupt its function. In addition, the C-terminal domain of RPSAP41 is involved in the formation of a RNA-protein complex, which can be targeted by small molecules that disrupt this interaction.

In conclusion, RPSAP41 is a protein that has been shown to play a critical role in regulating gene expression and has potential as a drug target or biomarker for the development of various diseases. The N-terminal domain of RPSAP41 is prone to oxidation and modification, which can affect its stability and localization, making it an attractive target for small molecules. The C-terminal domain of RPSAP41 is involved in the formation of a RNA-protein

Protein Name: Ribosomal Protein SA Pseudogene 41

The "RPSAP41 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPSAP41 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets